The experts on your list may not be the ones your programme needs.
Kendle Healthcare helps Medical Affairs and Product teams identify and engage the right KOLs for their specific product, mechanism, and strategy. For more than 20 years, we have helped teams make expert decisions they can stand behind.
0 +
Years Experience
0 +
Experts
0 +
Disease Areas
23+ years supporting Medical Affairs, Marketing, and Product teams
Trusted by global pharma, biotech, and Medical Communications teams
Strong experience across autoimmune, respiratory, oncology, and rare diseases.
Deep regional expertise in Japan and China
why most KOL lists miss the mark
Most KOL lists are built for scale, not for your situation.
Most KOL services begin by identifying influential clinicians within a specialty using data sources built for scale: publications, citation counts, society roles, congress activity. A standard scoring model is then applied across every specialty, every disease area, and every client.
The process is consistent: identify the KOLs within a specialty, then identify which of those are active in the disease area you care about.
It is not a bad approach, but it is only designed to work at scale, not to find the KOLs most relevant to you. A scoring model built to generalise will surface the same names every time. Your competitors are looking at those names too.
The names that surface are predictable. The names that do not are the problem.
Why it impacts your programme
The consequences surface later.
A list built on general prominence often looks credible on paper. The problems show up in use.
Advisory boards that generate little actionable insight. Engagement budgets directed at the wrong people. Regional expertise that never appears because it does not register in global datasets. Senior KOLs whose influence does not extend to the specific disease context your programme depends on.
When those decisions need defending internally, in governance meetings, launch planning, or Medical review, a list you cannot fully justify becomes a real problem.
What moves your programme forward
Expert intelligence built around the decision you're actually making.
Most identification stops at prominence.
Kendle Healthcare starts with your product, your mechanism, and the specific decisions your programme needs to support. Different starting point.
Different scoring. Often, different people on the list.
The goal is not a longer list, or a faster one.
It is the right experts for the decisions you are making, with a clear rationale for why they are there and how they should be engaged. Every project is led directly by experienced specialists. Outputs are documented to withstand internal scrutiny, regulatory review, and governance sign-off.
Case Study
What clients find when they compare approaches.
Shortlists composed differently, with regional leaders and emerging experts alongside globally visible figures, a clear rationale for each inclusion, and guidelines or working groups they were not previously aware of.
Two ways we work
KOL Identification & Mapping
We identify and prioritise experts within the exacting scientific and strategic context of your programme.
Testimonials
What our clients say
Everything is then designed to provide you with the KOL map you need to plan and execute successful KOL engagement.
Let's talk about your expert landscape.
The right experts depend on the right question.